MetLife Investment Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $574K | Buy |
91,110
+2,078
| +2% | +$13.1K | ﹤0.01% | 1609 |
|
2025
Q1 | $571K | Sell |
89,032
-4,415
| -5% | -$28.3K | ﹤0.01% | 1664 |
|
2024
Q4 | $751K | Buy |
93,447
+11,725
| +14% | +$94.3K | ﹤0.01% | 1569 |
|
2024
Q3 | $1.03M | Hold |
81,722
| – | – | 0.01% | 1372 |
|
2024
Q2 | $1.03M | Buy |
81,722
+23,225
| +40% | +$294K | 0.01% | 1331 |
|
2024
Q1 | $280K | Buy |
58,497
+12,479
| +27% | +$59.7K | ﹤0.01% | 1997 |
|
2023
Q4 | $221K | Hold |
46,018
| – | – | ﹤0.01% | 2189 |
|
2023
Q3 | $333K | Hold |
46,018
| – | – | ﹤0.01% | 1878 |
|
2023
Q2 | $342K | Buy |
46,018
+40,816
| +785% | +$303K | ﹤0.01% | 1942 |
|
2023
Q1 | $36.1K | Buy |
5,202
+485
| +10% | +$3.36K | ﹤0.01% | 2738 |
|
2022
Q4 | $48.5K | Sell |
4,717
-124
| -3% | -$1.28K | ﹤0.01% | 2765 |
|
2022
Q3 | $88.1K | Buy |
4,841
+3
| +0.1% | +$55 | ﹤0.01% | 2711 |
|
2022
Q2 | $249K | Sell |
4,838
-39
| -0.8% | -$2.01K | ﹤0.01% | 2160 |
|
2022
Q1 | $359K | Buy |
+4,877
| New | +$359K | ﹤0.01% | 1985 |
|
2021
Q2 | – | Sell |
-22,592
| Closed | -$4.1M | – | 2470 |
|
2021
Q1 | $4.1M | Sell |
22,592
-1,954
| -8% | -$354K | 0.04% | 494 |
|
2020
Q4 | $2.74M | Sell |
24,546
-1,077
| -4% | -$120K | 0.03% | 671 |
|
2020
Q3 | $2.78M | Hold |
25,623
| – | – | 0.03% | 574 |
|
2020
Q2 | $2.14M | Buy |
25,623
+10,828
| +73% | +$903K | 0.02% | 686 |
|
2020
Q1 | $201K | Buy |
+14,795
| New | +$201K | ﹤0.01% | 1694 |
|
2019
Q1 | – | Sell |
-9,069
| Closed | -$334K | – | 2584 |
|
2018
Q4 | $334K | Hold |
9,069
| – | – | ﹤0.01% | 1613 |
|
2018
Q3 | $341K | Sell |
9,069
-237
| -3% | -$8.91K | ﹤0.01% | 1777 |
|
2018
Q2 | $249K | Buy |
9,306
+2,368
| +34% | +$63.4K | ﹤0.01% | 1818 |
|
2018
Q1 | $291K | Hold |
6,938
| – | – | ﹤0.01% | 1687 |
|
2017
Q4 | $172K | Buy |
+6,938
| New | +$172K | ﹤0.01% | 2006 |
|